MIT Dropouts Raise $32M at $300M Valuation - TechCrunch

Delve Secures $32 Million Series A Funding

Karun Kaushik and Selin Kocalar did not initially intend to pursue a Series A funding round so quickly. Their AI-driven compliance startup, Delve, which had previously announced a $3 million seed round in January, was experiencing rapid growth and consistently acquiring new clients.

However, significant inbound interest began to materialize, as COO Kocalar explained to TechCrunch.

Series A Details and Valuation

Delve, specializing in the automation of AI regulatory compliance, ultimately received and evaluated multiple investment offers. This culminated in a successful $32 million Series A funding round, establishing a company valuation of $300 million. Insight Partners spearheaded the round, contributing the majority of the capital, with additional participation from CISOs representing Fortune 500 corporations.

The COO emphasized that Insight Partners has proven to be a valuable collaborator and aligns with their long-term strategic vision.

This new valuation signifies approximately a tenfold increase compared to the previous funding round. Concurrently, Delve’s client base has expanded from 100 companies reported in January to over 500, including prominent AI startups such as Lovable, Bland, and Wispr Flow.

From Medical Scribes to Compliance Automation

The company, comprised of AI researchers from MIT, Stanford, and Berkeley, has achieved notable success by leveraging AI to streamline processes and eliminate substantial manual effort. However, its origins were quite different.

Kaushik and Kocalar first connected as freshmen at MIT, sharing a common passion for AI and health technology. Kaushik had previously developed and scaled a COVID diagnostic system to serve thousands of users during the pandemic.

In 2023, their initial focus was on creating an AI-powered medical scribe designed to assist doctors with patient documentation. However, the handling of sensitive healthcare data quickly highlighted the complexities and costs associated with HIPAA compliance.

This realization prompted a strategic shift. Instead of pursuing the medical scribe, they began developing tools to facilitate faster and more affordable HIPAA compliance for other organizations. This pivot led to their acceptance into Y Combinator and the subsequent securing of their seed funding from General Catalyst, FundersClub, Soma Capital, and others. Both founders made the decision to leave MIT during their sophomore year in 2023.

Expanding Beyond HIPAA

Initially centered around HIPAA, the scope of Delve’s offerings broadened as their customer base grew. “Customers began requesting assistance with other frameworks, including SOC 2, PCI, GDPR, and ISO – essentially the entire spectrum of compliance requirements,” Kocalar stated.

The Bottleneck of Manual Compliance

Compliance documentation is often a prerequisite for launching products and finalizing enterprise agreements. However, this manual work can impede progress and hinder growth.

“While compliance frameworks are standardized, businesses are not,” explains CEO Kaushik. “This discrepancy is the reason why conventional software often fails, leading teams to rely on improvised solutions using email, Slack, and shared drives.”

Delve’s AI-Powered Solution

Delve addresses this challenge by deploying AI agents that operate in the background, integrating seamlessly with existing customer tools. These agents function as virtual team members, gathering evidence, generating reports, maintaining audit logs, and monitoring configuration changes across disparate systems, thereby automating compliance workflows in real-time.

Kocalar envisions compliance as a gateway to broader back-office automation. The company’s long-term objective is to automate a billion hours of work, extending into areas such as cybersecurity, risk management, and internal governance.

Insight Partners’ Perspective

Insight Partners’ investment reflects this ambitious roadmap.

“Given that compliance impacts every facet of a business – from scaling operations to closing deals and fostering customer trust – modernizing this function will modernize the entire organization,” said Praveen Akkiraju, managing director at Insight. “Delve’s approach is therefore exceptionally significant.”

Competitive Landscape and Future Outlook

Despite the potential, Delve will encounter competition. Several AI companies are developing agents to automate business processes. Furthermore, major AI research labs, such as OpenAI, are releasing versatile agents capable of handling complex tasks.

However, Kocalar views these developments as validation of Delve’s business model, rather than a threat. She highlights the company’s specialized expertise in contrast to more generalized agents.

“We are strategically positioning ourselves to capitalize on advancements in AI and the introduction of more sophisticated agentic technologies. However, our core differentiator lies in the profound, domain-specific knowledge we are embedding within the platform,” she stated. “Compliance is a constantly evolving field, with new regulations emerging and existing ones being reinterpreted, and companies applying them in diverse ways. This is where Delve excels.”